
Advanced International Journal for Research
E-ISSN: 3048-7641
•
Impact Factor: 9.11
A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal
Home
Research Paper
Submit Research Paper
Publication Guidelines
Publication Charges
Upload Documents
Track Status / Pay Fees / Download Publication Certi.
Editors & Reviewers
View All
Join as a Reviewer
Get Membership Certificate
Current Issue
Publication Archive
Conference
Publishing Conf. with AIJFR
Upcoming Conference(s) ↓
WSMCDD-2025
GSMCDD-2025
Conferences Published ↓
RBS:RH-COVID-19 (2023)
ICMRS'23
PIPRDA-2023
Contact Us
Plagiarism is checked by the leading plagiarism checker
Call for Paper
Volume 6 Issue 5
September-October 2025
Indexing Partners



















Hydroxyurea-Induced Non-Healing Leg Ulcer in Essential Thrombocythemia: A Case Report
Author(s) | Dr Aman Kumar |
---|---|
Country | India |
Abstract | Hydroxyurea is a first-line cytoreductive agent for high-risk essential thrombocythemia (ET) due to its efficacy in reducing thrombotic events. Although generally well tolerated, long-term use may lead to rare cutaneous complications, notably non-healing leg ulcers. We report the case of a 52-year-old female with triple-negative ET who developed a painful ulcer above the left lateral malleolus after three years of hydroxyurea therapy. Initial evaluation, including venous Doppler, ruled out vascular pathology. Despite standard wound management, the ulcer progressed, prompting suspicion of a drug-induced etiology. Hydroxyurea was discontinued, and anagrelide was initiated, resulting in complete ulcer healing within three months. Hydroxyurea-induced ulcers are thought to result from cytotoxic damage to keratinocytes and endothelial cells, impairing microvascular function and delaying healing. Clinicians should maintain a high index of suspicion for drug-induced ulcers in ET patients on long-term hydroxyurea therapy to avoid unnecessary interventions. Early withdrawal of hydroxyurea and initiation of alternative agents such as anagrelide can ensure favorable outcomes. |
Keywords | Hydroxyurea, Essential thrombocythemia, Non-healing ulcer, Leg ulcer, Anagrelide, Drug-induced skin injury |
Field | Medical / Pharmacy |
Published In | Volume 6, Issue 4, July-August 2025 |
Published On | 2025-08-19 |
DOI | https://doi.org/10.63363/aijfr.2025.v06i04.1118 |
Short DOI | https://doi.org/g9zzbx |
Share this

E-ISSN 3048-7641

CrossRef DOI is assigned to each research paper published in our journal.
AIJFR DOI prefix is
10.63363/aijfr
All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.
